Clinical Research Directory
Browse clinical research sites, groups, and studies.
PROMUS PREMIER™ China Post-Approval Study
Sponsor: Boston Scientific Corporation
Summary
To compile real-world clinical outcome data for the Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System (Promus PREMIERTM Stent System) in routine clinical practice in China.
Official title: Post-Approval Study of the PROMUS PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System in China
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2059
Start Date
2018-01-11
Completion Date
2025-10-03
Last Updated
2026-07-22
Healthy Volunteers
No
Conditions
Interventions
Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System
Promus PREMIERTM Stent System
Locations (1)
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China